4-112515322-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_024019.4(NEUROG2):​c.154C>T​(p.Arg52Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000705 in 1,419,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000063 ( 0 hom. )

Consequence

NEUROG2
NM_024019.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.989
Variant links:
Genes affected
NEUROG2 (HGNC:13805): (neurogenin 2) This gene encodes a neural-specific basic helix-loop-helix (bHLH) transcription factor that can specify a neuronal fate on ectodermal cells and is expressed in neural progenitor cells within the developing central and peripheral nervous systems. The protein product of this gene also plays a role in the differentiation and survival of midbrain dopaminergic neurons. [provided by RefSeq, Apr 2012]
NEUROG2-AS1 (HGNC:40656): (NEUROG2 and ZGRF1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06129986).
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEUROG2NM_024019.4 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 2 ENST00000313341.4 NP_076924.1 Q9H2A3
NEUROG2-AS1NR_161159.1 linkn.-57G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEUROG2ENST00000313341.4 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 2 1 NM_024019.4 ENSP00000317333.3 Q9H2A3
NEUROG2-AS1ENST00000504009.1 linkn.-109G>A upstream_gene_variant 3
NEUROG2-AS1ENST00000506057.1 linkn.-63G>A upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151844
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000596
AC:
6
AN:
100642
Hom.:
0
AF XY:
0.0000339
AC XY:
2
AN XY:
58996
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00126
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000631
AC:
8
AN:
1267584
Hom.:
0
Cov.:
33
AF XY:
0.00000481
AC XY:
3
AN XY:
623070
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000198
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.75e-7
Gnomad4 OTH exome
AF:
0.0000192
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151844
Hom.:
0
Cov.:
33
AF XY:
0.0000270
AC XY:
2
AN XY:
74182
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151
ExAC
AF:
0.0000776
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 07, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.154C>T (p.R52C) alteration is located in exon 2 (coding exon 1) of the NEUROG2 gene. This alteration results from a C to T substitution at nucleotide position 154, causing the arginine (R) at amino acid position 52 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
18
DANN
Benign
0.90
DEOGEN2
Benign
0.25
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.31
N
LIST_S2
Benign
0.64
T
M_CAP
Pathogenic
0.78
D
MetaRNN
Benign
0.061
T
MetaSVM
Uncertain
-0.23
T
MutationAssessor
Benign
0.69
N
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
0.060
N
REVEL
Benign
0.24
Sift
Uncertain
0.0010
D
Sift4G
Benign
0.18
T
Polyphen
0.99
D
Vest4
0.12
MutPred
0.38
Loss of MoRF binding (P = 0.0252);
MVP
0.81
MPC
0.91
ClinPred
0.17
T
GERP RS
2.5
Varity_R
0.10
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767284154; hg19: chr4-113436478; API